These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 19157643)

  • 61. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
    Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Methicillin resistant Staphylococcus aureus endocarditis in an Australian tertiary hospital: 1991-2006.
    Rogers BA; Drake AK; Spelman D
    Heart Lung Circ; 2009 Jun; 18(3):208-13. PubMed ID: 19119075
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Current perspective of the HCAP problem: is it CAP or is it HAP?
    Polverino E; Torres A
    Semin Respir Crit Care Med; 2009 Apr; 30(2):239-48. PubMed ID: 19296421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. What is healthcare-associated pneumonia, and how should it be treated?
    Craven DE
    Curr Opin Infect Dis; 2006 Apr; 19(2):153-60. PubMed ID: 16514340
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nosocomial pneumonia in a pediatric intensive care unit.
    Patra PK; Jayashree M; Singhi S; Ray P; Saxena AK
    Indian Pediatr; 2007 Jul; 44(7):511-8. PubMed ID: 17939179
    [TBL] [Abstract][Full Text] [Related]  

  • 67. What is healthcare-associated pneumonia and how is it managed?
    Carratalà J; Garcia-Vidal C
    Curr Opin Infect Dis; 2008 Apr; 21(2):168-73. PubMed ID: 18317041
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
    Frei CR; Restrepo MI; Mortensen EM; Burgess DS
    Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Selection of empirical antibiotics for health care-associated pneumonia via integration of pneumonia severity index and risk factors of drug-resistant pathogens.
    Wang PH; Wang HC; Cheng SL; Chang HT; Laio CH
    J Formos Med Assoc; 2016 May; 115(5):356-63. PubMed ID: 25944735
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Epidemiology of infections at the intensive care unit].
    Siegel T; Mikaszewska-Sokolewicz M; Mayzner-Zawadzka E
    Pol Merkur Lekarski; 2006 Mar; 20(117):309-14. PubMed ID: 16780263
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Healthcare-associated pneumonia - is this new entity important for diagnosis and treatment of pneumonia? contra].
    Ewig S
    Dtsch Med Wochenschr; 2010 Mar; 135(10):467. PubMed ID: 20198545
    [No Abstract]   [Full Text] [Related]  

  • 72. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres.
    Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC
    J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical presentation and predictors of outcome in adult patients with community-acquired pneumonia.
    Dey AB; Nagarkar KM; Kumar V
    Natl Med J India; 1997; 10(4):169-72. PubMed ID: 9325639
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients.
    Hanes SD; Demirkan K; Tolley E; Boucher BA; Croce MA; Wood GC; Fabian TC
    Clin Infect Dis; 2002 Aug; 35(3):228-35. PubMed ID: 12115086
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of an institution-specific hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes.
    Lancaster JW; Lawrence KR; Fong JJ; Doron SI; Garpestad E; Nasraway SA; Devlin JW
    Pharmacotherapy; 2008 Jul; 28(7):852-62. PubMed ID: 18576900
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia.
    Metersky ML; Frei CR; Mortensen EM
    Respirology; 2016 Jan; 21(1):157-63. PubMed ID: 26682638
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Causes of nosocomial pneumonia and evaluation of risk factors in a university hospital in Turkey.
    Savas L; Onlen Y; Duran N; Savas N
    Saudi Med J; 2007 Jan; 28(1):114-20. PubMed ID: 17206302
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of severity scoring and stratification factors in clinical trials of hospital-acquired and ventilator-associated pneumonia.
    Napolitano LM
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S67-80. PubMed ID: 20597675
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hospital-acquired pneumonia in ICU patients.
    Uvizl R; Hanulik V; Husickova V; Sedlakova MH; Adamus M; Kolar M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Dec; 155(4):373-8. PubMed ID: 22336651
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The pathogens and their antibiotic sensitivities in hospital-acquired pneumonia cases].
    Kaynar H; Yilmaz N; Sağlam L; Meral M; Altoparlak U; Görgüner M; Mirici A
    Tuberk Toraks; 2004; 52(4):333-40. PubMed ID: 15558355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.